Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Grazoprevir impurity 1 is a structural variant of Grazoprevir, a direct-acting antiviral agent targeting the hepatitis C virus (HCV) protease. This impurity is utilized in analytical chemistry for impurity profiling and quality control in pharmaceutical development. Its characterization is essential for ensuring the purity and safety of Grazoprevir formulations in research and clinical applications. -
Drug Impurity
Abacavir impurity 6 is a metabolite of Abacavir, primarily identified as a drug impurity. This compound may be of interest during the quality control and analytical assessment of Abacavir formulations. Its presence can provide insights into the stability and degradation pathways of the active pharmaceutical ingredient in biological and pharmaceutical research. -
Drug Impurity
Candesartan impurity 18 is a known impurity associated with the angiotensin II receptor antagonist, Candesartan. This compound serves as a reference standard for quality control and analytical studies in pharmaceutical development. It is essential for ensuring the integrity and compliance of Candesartan formulations in research and development settings. -
Drug Impurity
Simvastatin impurity 3 is a chemical impurity associated with the cholesterol-lowering agent Simvastatin. This compound is primarily utilized in drug formulation analysis to identify and quantify impurities in the synthesis of Simvastatin. Its presence is critical for ensuring the quality and safety of pharmaceutical products, making it an essential reagent for regulatory compliance and formulation development in the pharmaceutical industry. -
Drug Impurity
Trazodone impurity 19 is a known impurity associated with the antidepressant trazodone. It plays a significant role in quality control and assessment within pharmaceutical development, helping to ensure the purity and safety of drug formulations. This compound can be utilized in research applications to study trazodone's stability and degradation pathways, facilitating the development of more effective antidepressant therapies. -
Drug Impurity
Azilsartan impurity 20, also known as Azilsartan amidoxime, is a chemical impurity associated with the pharmaceutical compound Azilsartan. Its presence is important for ensuring the quality and safety of pharmaceutical formulations. This compound is primarily utilized in quality control and analytical research to assess the purity of Azilsartan and evaluate its synthesis processes. -
Drug Impurity
Sofosbuvir impurity 5 is a known impurity of the antiviral drug Sofosbuvir, which targets the RNA-dependent RNA polymerase of hepatitis C virus. This compound is essential for analytical research and quality control in the development of Sofosbuvir formulations. Its characterization and quantification are important for ensuring the purity and efficacy of the final pharmaceutical product. -
Drug Impurity
Irbesartan impurity 1 is a byproduct associated with the synthesis of Irbesartan, an angiotensin II receptor blocker. This chemical is essential for quality control and method validation in pharmaceutical research and development. Its characterization is crucial for ensuring the safety and efficacy of the final drug product, supporting regulatory compliance and analytical assessments. -
Drug Impurity
Amlodipine impurity 3 is a specific impurity associated with the calcium channel blocker Amlodipine. This compound is significant for drug quality assessments and regulatory compliance in pharmaceutical research. It is utilized in the development and validation of analytical methods for the quantification and characterization of impurities in drug formulations. -
Drug Impurity
Aripiprazole impurity 26, also known as N-(Chloroacetyl)-m-anisidide, is identified as a drug impurity associated with Aripiprazole. This compound is of interest for analytical chemistry and quality control in pharmaceutical research, assisting in the characterization and validation of drug substances. Its presence may be relevant in studying the purity and stability of Aripiprazole formulations. -
Drug Impurity
Candesartan impurity 10 is a structural impurity related to Candesartan, an angiotensin II receptor blocker. This compound is primarily utilized for quality control and analytical purposes in the development and production of Candesartan pharmaceuticals. Its identification and quantification are essential for ensuring the purity and regulatory compliance of Candesartan formulations in drug development. -
Drug Impurity
Salmeterol impurity 4, also known as Salmeterol impurity G, is a known impurity associated with the beta-2 adrenergic agonist Salmeterol. Its presence is important for quality control and analytical studies of Salmeterol formulations. Researchers can utilize this impurity to assess the purity and stability of Salmeterol during drug development processes. -
Drug Impurity
Telmisartan impurity 6 is a synthetic byproduct of Telmisartan, functioning primarily as a drug impurity. It is important for quality control and analytical studies in pharmacological research, assisting in the assessment of pharmaceutical formulations and safety profiles. This impurity is useful in understanding the stability and degradation pathways of Telmisartan, contributing to the overall evaluation of drug quality and efficacy. -
Drug Impurity
Ketoprofen Impurity 7 is a chemical impurity associated with the nonsteroidal anti-inflammatory drug, Ketoprofen. It serves as an important reference standard for method development and validation in pharmaceutical research and quality control. Investigating this impurity facilitates a better understanding of Ketoprofen’s chemical profile, stability, and potential effects on drug performance and safety. -
Drug Impurity
Edoxaban impurity 14, known as (1R,2S,5S)-2-Amino edoxaban, is a chemical impurity of the anticoagulant Edoxaban. This compound is utilized primarily for quality control and analytical purposes in pharmaceutical research. Its characterization and analysis are essential for ensuring the purity and safety of Edoxaban formulations in drug development and regulatory compliance. -
Drug Impurity
Pantoprazole impurity 2, also known as Pantoprazole dimer, serves as a drug impurity associated with Pantoprazole. Its presence is significant in the context of pharmaceutical quality control and stability studies. This compound is utilized in research applications focused on the assessment of drug purity, formulation development, and regulatory compliance in the pharmaceutical industry. -
Drug Impurity
Ciprofloxacin impurity 3 is a known impurity associated with the antibiotic ciprofloxacin. As a drug impurity, it plays a crucial role in analytical chemistry, particularly in the development and validation of analytical techniques for residual impurity quantification in pharmaceutical formulations. Understanding and characterizing such impurities is essential for ensuring the safety and efficacy of ciprofloxacin in clinical applications. -
Drug Impurity
Prednisolone Impurity 4 is a structural impurity associated with the corticosteroid Prednisolone. This compound is relevant in pharmaceutical research for the characterization and analysis of drug formulations. It serves as a reference standard in the assessment of drug purity and stability during quality control processes. -
Drug Impurity
Apixaban impurity 49 is a chemical impurity associated with the anticoagulant agent Apixaban. This compound is crucial for quality control and analytical applications within pharmaceutical research, enabling the assessment of impurity profiles and compliance with regulatory standards. It serves as an important reference standard for the development and validation of analytical methods in drug formulation and stability studies. -
Drug Impurity
Rivastigmine impurity 5 is a designated impurity associated with the cholinesterase inhibitor Rivastigmine. This compound serves as a critical reference standard for quality control and analytical chemistry in pharmaceutical research. Its analysis is essential for ensuring the purity of Rivastigmine formulations, thereby supporting regulatory compliance and safety assessments in drug development. -
Drug Impurity
Doxepin impurity 1 hydrochloride is a chemical impurity associated with Doxepin, a tricyclic antidepressant. Its identification and characterization are crucial for ensuring the purity and safety of pharmaceutical formulations. This reagent provides essential insights into drug quality control and is primarily utilized in analytical chemistry and pharmacological research to assess the presence and concentration of impurities in drug substances. -
Drug Impurity
Exatecan intermediate 13 is a known impurity of the chemotherapeutic agent Exatecan, which primarily targets DNA topoisomerase I. This compound serves as a valuable research tool for the study of drug impurities and their impact on pharmacological activity. It is essential for assessing the purity of Exatecan in drug development and evaluating potential effects on efficacy and safety profiles in cancer research applications. -
Drug Impurity
Acyclovir impurity 1 is a chemical impurity associated with the antiviral drug Acyclovir. This reagent is essential for quality control and analytical studies in the development and assessment of Acyclovir formulations. Its identification and characterization contribute to ensuring the purity and safety of antiviral therapeutics. -
Drug Impurity
Quetiapine impurity 8 (9-Chloro quetiapine) is a identified impurity of the antipsychotic drug Quetiapine. Its presence is relevant in the quality control and pharmacokinetic studies of Quetiapine formulations. The characterization of such impurities is essential for ensuring the safety and efficacy of pharmaceutical preparations in drug development and regulatory compliance. -
Drug Impurity
Donepezil impurity 1, also known as 3-Hydroxy donepezil, is a chemical impurity associated with the pharmacological agent Donepezil. It serves as an important analytical standard for quality control in pharmaceutical research, enabling the detection and quantification of impurities in Donepezil formulations. Its presence can impact the efficacy and safety profiles of the final drug products, making it essential for compliance in regulatory assessments and stability studies. -
Drug Impurity
Desmethylcitalopram hydrobromide is a notable drug impurity associated with the selective serotonin reuptake inhibitor (SSRI) citalopram. Its primary mechanism involves the modulation of serotonin levels in the central nervous system. This compound is significant for analytical chemistry studies focused on drug formulation, quality control, and pharmacokinetic research, providing insights into drug metabolism and safety profiles. -
Drug Impurity
Allopurinol impurity 2 is a known impurity associated with the drug Allopurinol, which primarily functions as a xanthine oxidase inhibitor. This compound is utilized in chemical research to study drug purity, stability, and potential side effects. Its characterization is essential for ensuring the quality and efficacy of Allopurinol formulations in therapeutic applications. -
Drug Impurity
Medroxyprogesterone acetate impurity 4 is an impurity associated with Medroxyprogesterone acetate, a synthetic progestin. This compound serves as a pivotal reference material for analytical studies and quality control in pharmaceutical development. Its characterization is crucial for understanding the purity and safety profiles of progestin-based formulations. -
Drug Impurity
Clindamycin palmitate impurity 12 (Clindamycin 2,3-dipalmitate) is a known drug impurity associated with clindamycin formulations. This compound can be utilized in analytical studies to assess the quality and stability of clindamycin products. Its presence may have implications for drug efficacy and safety, making it relevant for research into pharmaceutical formulations and impurity profiling. -
Drug Impurity
Moxifloxacin impurity 4 (8-Ethoxymoxifloxacin) is a notable impurity associated with the antibiotic Moxifloxacin. This compound is utilized primarily for the analysis of drug purity and quality control in pharmaceutical research. It serves as a standard reference material for assessing the presence of impurities in formulations, ensuring compliance with regulatory standards. Researchers can employ this impurity in method development or validation studies to enhance the reliability of analytical results in antibiotic formulation assessments. -
Drug Impurity
Ranolazine impurity 1, also known as Ranolazine bis(N-oxide), is a chemical impurity associated with the antianginal agent Ranolazine. This compound serves as a valuable reference standard for analytical and quality control purposes in pharmacological research. Its characterization is essential for assessing the purity and stability of Ranolazine formulations in drug development and regulatory compliance. -
Drug Impurity
Afatinib impurity 35 is a chemical impurity associated with the kinase inhibitor Afatinib, which targets epidermal growth factor receptor (EGFR) signaling pathways. This impurity can be utilized in the characterization and quality control of Afatinib formulations to ensure regulatory compliance and validate analytical methods. It serves as an important reference standard in pharmaceutical development and research involving EGFR-targeted therapies. -
Drug Impurity
Edaravone impurity 2 is a known impurity associated with Edaravone, a neuroprotective agent. This compound can be employed in the analysis of drug purity and stability in pharmaceutical research. Its characterization is essential for ensuring the quality and safety of Edaravone formulations in drug development and regulatory compliance. -
Drug Impurity
Itraconazole impurity 3 is a chemical impurity associated with the antifungal agent Itraconazole. This compound is crucial for analytical research and characterization of drug formulations. Its assessment can support regulatory compliance and quality control in pharmaceutical development. Itraconazole impurity 3 aids in understanding the stability and integrity of Itraconazole-related products. -
Drug Impurity
Sertraline impurity 8 is a known impurity of the antidepressant sertraline, acting primarily as a metabolic byproduct. This compound is important for analytical development and quality control in pharmaceutical research related to sertraline synthesis and formulation. Its characterization helps ensure the purity and safety of pharmaceutical products containing sertraline. -
Drug Impurity
Febuxostat impurity 15 is a chemical reagent classified as a drug impurity of febuxostat. It serves as an important marker for quality control and analytical studies during the synthesis and evaluation of febuxostat, a xanthine oxidase inhibitor. This impurity is crucial for ensuring the purity and safety of pharmaceutical formulations containing febuxostat, aiding researchers in understanding its metabolic pathways and potential effects. -
Drug Impurity
Thioridazine impurity 4, also known as Sulforidazine, is a structural impurity of Thioridazine. This compound may be present during the synthesis of Thioridazine and is relevant for analytical and quality control processes in pharmaceutical development. Research applications include the identification and quantification of impurities in drug formulations, providing essential data for ensuring drug safety and efficacy. -
Drug Impurity
Citalopram impurity 6 is a known impurity associated with the selective serotonin reuptake inhibitor (SSRI) Citalopram. This compound is utilized primarily in quality control and analytical studies to assess the purity of pharmaceutical formulations. Its characterization plays an important role in ensuring the safety and efficacy of Citalopram as well as in the development of analytical methods for pharmaceutical research. -
Drug Impurity
Imatinib impurity 2 is a chemical impurity associated with Imatinib, specifically relevant in pharmaceutical quality control. It serves as a vital reference standard for assessing the purity of Imatinib in bulk drug substances and formulations. This impurity is important for studies focusing on drug stability and toxicological evaluations, ensuring the safety and efficacy of Imatinib-related therapeutic applications. -
Drug Impurity
Quetiapine impurity 21 is a known impurity of the antipsychotic drug Quetiapine, primarily affecting the compound's purity assessment. This impurity can be utilized in the analysis of pharmaceutical formulations to ensure compliance with regulatory standards. Its presence can impact the pharmacological profile of Quetiapine, making it relevant in studies focused on drug development and quality control. -
Drug Impurity
Etoposide impurity 1 is a recognized impurity associated with the chemotherapeutic agent Etoposide. This compound serves as a valuable reference standard in the analysis of drug formulations and quality control processes. Its presence can impact the efficacy and safety profiles of Etoposide, making it significant for research into drug development and pharmacokinetics. -
Adrenaline Impurity
Methoxy adrenaline hydrochloride is a synthetic analog of adrenaline, serving as a known impurity in adrenaline formulations. Its presence is critical for quality control in pharmaceutical research, allowing for the assessment of purity and stability in adrenaline products. This compound can also be utilized in various biological studies to investigate adrenergic receptor interactions and signaling pathways. -
Drug Impurity
Canagliflozin impurity 5 is a known impurity of the antidiabetic agent Canagliflozin, which primarily functions as a sodium-glucose cotransporter 2 (SGLT2) inhibitor. This impurity may be useful in drug development studies and quality control processes to evaluate the purity of Canagliflozin formulations. It supports a range of research applications related to pharmacological assessments and safety profiling in the context of diabetes treatment. -
Drug Impurity
Meloxicam impurity 2 is a chemical impurity associated with Meloxicam, a non-steroidal anti-inflammatory drug (NSAID). This impurity is essential for comprehensive drug quality assessments and stability studies. Researchers can utilize Meloxicam impurity 2 to ensure the purity and efficacy of formulations in pharmaceutical development, facilitating compliance with regulatory standards. -
Drug Impurity
Metoprolol Impurity 13 is a chemical impurity associated with Metoprolol, a selective beta-1 adrenergic receptor antagonist. This impurity can be utilized for analytical purposes in drug development, including stability studies and quality control assessments. Researchers can employ this compound to ensure the purity and compliance of Metoprolol formulations in pharmaceutical applications. -
Drug Impurity
Metronidazole impurity 1 is a secondary compound associated with Metronidazole, serving as a drug impurity. This substance is often analyzed in quality control processes to ensure the purity of Metronidazole formulations. It is relevant in research applications focused on pharmacokinetics and safety assessment of drug products. -
Drug Impurity
Rivastigmine impurity 4 is a chemical impurity associated with Rivastigmine, a reversible inhibitor of acetylcholinesterase. This impurity is relevant in the quality control and analytical evaluation of Rivastigmine formulations. Research applications include pharmacokinetic studies and the assessment of drug stability. -
Drug Impurity
Hydrocortisone impurity 12 is a known impurity of hydrocortisone. This compound is primarily utilized in pharmaceutical development and analytical chemistry to assess the purity of hydrocortisone formulations. Its presence can impact the overall efficacy and safety profiles of steroid-based treatments, making it essential for quality control in drug manufacturing and regulatory compliance studies. -
Drug Impurity
Aripiprazole impurity 5 is a characterized impurity associated with the antipsychotic agent Aripiprazole. This compound is crucial for quality control and analysis in pharmaceutical development, facilitating the detection and quantification of impurities during drug synthesis. Its study can enhance understanding of Aripiprazole's stability and formulation, contributing to the overall safety and efficacy of antipsychotic therapies. -
Drug Impurity
Rebamipide methyl ester is a known impurity of Rebamipide, primarily utilized in chemical research. This compound serves as a reference standard for quality control and analytical purposes in the development and analysis of pharmaceuticals. Its presence can affect the potency and efficacy of formulations, making it essential for researchers studying the pharmacological properties of Rebamipide.
